Skip to content
lifestyle.gamezon.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
SK Life Science , Inc.
SK Biopharmaceuticals Submits Supplemental New Drug Application to U.S. FDA for Cenobamate
November 4, 2026
SK Life Science, Inc. Introduces Access+ to Simplify the Patient Support Experience
November 2, 2026
SK Life Science Supports SUDEP Awareness Efforts Through Partnership with CURE Epilepsy and The Cameron Boyce Foundation
October 14, 2026
SK Life Science, Inc. Announces FDA Acceptance for Review of New Drug Application for Cenobamate Oral Suspension
June 15, 2026